SCHEMBL6568634

SCHEMBL6568634

Cc1c(Cl)cc(NCc2ccccc2-c2ccccc2)c(O)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.46
BRD9 Q9H8M2 1/20 0.46
CD274 Q9NZQ7 9/20 0.43
PDCD1 Q15116 6/20 0.43
MAPT P10636 6/20 0.39
FFAR1 O14842 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
GAA P10253 2/20 0.38
TP53 P04637 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4351839 0.81 HDAC8 (0.45) BRD4BRD9MAPTHDAC1HDAC6
SCHEMBL4347334 0.80 CD38 (0.46) MAPTGAATP53MAPK1HSD17B10
SCHEMBL4346146 0.79 SMN1; SMN2 (0.41) MAPTGAATP53MAPK1HSD17B10
SCHEMBL4355466 0.79 CYP3A4 (0.44) MAPTHDAC3HDAC1HDAC2HDAC6
SCHEMBL4345509 0.78 MAPT (0.36) BRD4MAPTHDAC1HDAC6GAA
SCHEMBL4346931 0.78 PRMT1 (0.40) MAPTGAATP53MAPK1HSD17B10
SCHEMBL4348935 0.75 FABP4 (0.32) GAATP53HSD17B10MEN1ALDH1A1
SCHEMBL4343949 0.75 SLC6A4 (0.45) MAPTGAATP53MAPK1HSD17B10
SCHEMBL4345487 0.75 MAPT (0.39) MAPTGAATP53MAPK1HSD17B10
SCHEMBL11511026 0.74 CYP2A6 (0.48) BRD4BRD9MAPTFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed